Synergistic antileukemia effect of combinational gene therapy using murine β-defensin 2 and IL-18 in L1210 murine leukemia model

Gene Therapy

Volumn 14, Issue 15, 2007, Pages 1181-1187

  Xu, B ^a   Dong, C Y ^a   Zhang, F ^a   Lin, Y M ^a   Wu, K F ^a   Ma, X T ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; PLASMID VECTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG POTENTIATION; ENZYME RELEASE; FEMALE; GENE CONSTRUCT; GENE DIRECTED ENZYME PRODRUG THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMMUNE RESPONSE; LEUKEMIA L 1210; LYMPHOCYTOTOXICITY; MONOTHERAPY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

ANIMALS; BETA-DEFENSINS; BIOLOGICAL ASSAY; CANCER VACCINES; CELL LINE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-1BETA; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC; LYMPHOCYTE ACTIVATION; MICE; MODELS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TRANSGENES;

MURINAE; MUS;

EID: 34447617896     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302966     Document Type: Article

References (23)

1. Medzhitov R, Janeway Jr C. Innate immunity. N Engl J Med 2000; 343: 338-344.
2. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002; 298: 1025-1029.
3. Ma XT, Xu B, An LL, Dong CY, Lin YM, Shi Y et al. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res 2006; 66: 1169-1176.
4. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88-91.
5. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 1995; 63: 3966-3972.
6. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H et al. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997; 159: 3961-3967.
7. Oshikawa K, Shi F, Rakhmilevich AL, Sondel PM, Mahvi DM, Yang NS. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA. Proc Natl Acad Sci USA 1999; 96: 13351-13356.
8. Iwasaki T, Yamashita K, Tsujimura T, Kashiwamura S, Tsutsui H, Kaisho T et al. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice. J Immunother 2002; 25 (Suppl. 1): S52-S60.
9. Zhang B, Wu XF, Lin YM, Ma XT, Rao Q, Zheng GG et al. Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells. Leukemia 2004; 18: 817-825.
10. Fukao T, Matsuda S, Koyasu S. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J Immunol 2000; 164: 64-71.
11. Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM et al. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors. J Immunol 2006; 177: 6962-6973.
12. Corthay A. A three-cell model for activation of naive T helper cells. Scand J Immunol 2006; 64: 93-96.
13. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275: 206-209.
14. Kimura F, Douzono M, Ohta J, Morita T, Ikeda K, Nakamura Y et al. Augmentation of antitumor immunity using genetically M-CSF-expressing L1210 cells. Exp Hematol 1996; 24: 360-363.
15. Dunussi-Joannopoulos K, Runyon K, Erickson J, Schaub RG, Hawley RG, Leonard JP. Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity. Blood 1999; 94: 4263-4273.
16. Zibert A, Balzer S, Souquet M, Quang TH, Paris-Scholz C, Roskrow M et al. CCL3/MIP-1alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine. Hum Gene Ther 2004; 15: 21-34.
17. Saudemont A, Buffenoir G, Denys A, Desreumaux P, Jouy N, Hetuin D et al. Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia. Leukemia 2002; 16 1637-1644.
18. Stripecke R, Levine AM, Pullarkat V, Cardoso AA. Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods. Leukemia 2002; 16: 1974-1983.
19. Chaudhry UI, Kingham TP, Plitas G, Katz SC, Raab JR, DeMatteo RP. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth. Cancer Res 2006; 66: 10497-10504.
20. Li Q, Carr AL, Donald EJ, Skitzki JJ, Okuyama R, Stoolman LM et al. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern. Cancer Res 2005; 65 1063-1070.
21. Stagg J, Wu JH, Bouganim N, Galipeau J. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy Cancer Res 2004; 64: 8795-8799.
22. Liu B, Novick D, Kim SH, Rubinstein M. Production of a biologically active human interleukin 18 requires its prior synthesis as pro-IL-18. Cytokine 2000; 12: 1519-1525.
23. Fukumoto H, Nishio M, Nishio, K, Heike Y, Arioka H, Kurokawa H et al. Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo. Jpn J Cancer Res 1997; 88: 501-505.